Alogliptin added to sulfonylurea therapy in patients with type 2 diabetes reduces HbA1c without increasing hypoglycemia

被引：0
|
作者：
Pratley, Richard
Kipnes, Mark
Fleck, Penny
Wilson, Craig
Mekki, Qais
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [41] The Relation Between HbA1c and Cardiovascular Events in Patients With Type 2 Diabetes With and Without Vascular Disease
    Kranenburg, Guido
    van der Graaf, Yolanda
    van der Leeuw, Joep
    Nathoe, Hendrik M. W.
    de Borst, Gert Jan
    Kappelle, L. Jaap
    Visseren, Frank L. J.
    Westerink, Jan
    DIABETES CARE, 2015, 38 (10) : 1930 - 1936
  • [42] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Jiaqi Hu
    Huichun Hsu
    Xiaodan Yuan
    Kezheng Lou
    Cunyi Hsue
    Joshua D. Miller
    Juming Lu
    Yaujiunn Lee
    Qingqing Lou
    Journal of Endocrinological Investigation, 2021, 44 : 1229 - 1236
  • [43] HbA1c trajectories in type 2 diabetes patients: The Diabetes Care System cohort
    Nijpels, G.
    Walraven, I.
    Mast, M. R.
    Hoekstra, T.
    Jansen, A. P. D.
    van der Heijden, A. A. W.
    Rauh, S. P.
    Rutters, F.
    van 't Riet, E.
    Elders, P. J. M.
    Moll, A. C.
    Polak, B. C. P.
    Dekker, J. M.
    DIABETOLOGIA, 2014, 57 : S114 - S115
  • [44] Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes
    Rama Chandran, Suresh
    Tay, Wei Lin
    Lye, Weng Kit
    Lim, Lee Ling
    Ratnasingam, Jeyakantha
    Tan, Alexander Tong Boon
    Gardner, Daphne S. L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (05) : 353 - 362
  • [45] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Hu, Jiaqi
    Hsu, Huichun
    Yuan, Xiaodan
    Lou, Kezheng
    Hsue, Cunyi
    Miller, Joshua D.
    Lu, Juming
    Lee, Yaujiunn
    Lou, Qingqing
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (06) : 1229 - 1236
  • [46] Canagliflozin reduces both HbA1c and body weight in patients with type 2 diabetes mellitus on background metformin
    Langslet, G.
    Davidson, J. A.
    Valentine, V.
    Vijapurkar, U.
    Canovatchel, W.
    Meininger, G.
    DIABETOLOGIA, 2014, 57 : S348 - S348
  • [47] Relationship Between HbA1c on Target, Risk of Silent Hypoglycemia and Glycemic Variability in Patients with Type 2 Diabetes Mellitus
    Engler, B.
    Koehler, C.
    Hoffmann, C.
    Landgraf, W.
    Bilz, S.
    Schoner, C.
    Bornstein, S. R.
    Hanefeld, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (01) : 59 - 61
  • [48] Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
    Kolterman, O
    Maggs, D
    Fineman, M
    Burrell, T
    Strobel, S
    Shen, L
    Weyer, C
    DIABETOLOGIA, 2002, 45 : A240 - A240
  • [49] Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
    Ratner, R
    Whitehouse, F
    Fineman, MS
    Strobel, S
    Shen, L
    Maggs, DG
    Kolterman, OG
    Weyer, C
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (04) : 199 - 204
  • [50] Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials
    Qian Lv
    Jie Shen
    Lin Miao
    Binqi Ye
    Cornelia Schepers
    Arian Plat
    Yongquan Shi
    Diabetes Therapy, 2020, 11 : 1317 - 1330
12345